These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8187066)

  • 1. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors.
    Orlow I; Lianes P; Lacombe L; Dalbagni G; Reuter VE; Cordon-Cardo C
    Cancer Res; 1994 Jun; 54(11):2848-51. PubMed ID: 8187066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.
    Czerniak B; Chaturvedi V; Li L; Hodges S; Johnston D; Roy JY; Luthra R; Logothetis C; Von Eschenbach AC; Grossman HB; Benedict WF; Batsakis JG
    Oncogene; 1999 Feb; 18(5):1185-96. PubMed ID: 10022124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
    Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK
    Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31.
    Simoneau M; Aboulkassim TO; LaRue H; Rousseau F; Fradet Y
    Oncogene; 1999 Jan; 18(1):157-63. PubMed ID: 9926930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite alterations at chromosomes 9p, 13q, and 17p in nonmuscle-invasive transitional cell carcinomas of the urinary bladder.
    Erbersdobler A; Friedrich MG; Schwaibold H; Henke RP; Huland H
    Oncol Res; 1998; 10(8):415-20. PubMed ID: 10100758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci.
    Habuchi T; Devlin J; Elder PA; Knowles MA
    Oncogene; 1995 Oct; 11(8):1671-4. PubMed ID: 7478593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.
    van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC
    Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for two bladder cancer suppressor loci on human chromosome 9.
    Ruppert JM; Tokino K; Sidransky D
    Cancer Res; 1993 Nov; 53(21):5093-5. PubMed ID: 8221642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular alterations associated with bladder cancer initiation and progression.
    Cordon-Cardo C
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.
    Tsai YC; Nichols PW; Hiti AL; Williams Z; Skinner DG; Jones PA
    Cancer Res; 1990 Jan; 50(1):44-7. PubMed ID: 2293558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma.
    Polascik TJ; Cairns P; Chang WY; Schoenberg MP; Sidransky D
    Cancer Res; 1995 Nov; 55(22):5396-9. PubMed ID: 7585608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic instability analysis of urine sediment versus tumor tissue in transitional cell carcinoma of the urinary bladder.
    Turyn J; Matuszewski M; Schlichtholz B
    Oncol Rep; 2006 Jan; 15(1):259-65. PubMed ID: 16328066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder.
    Keen AJ; Knowles MA
    Oncogene; 1994 Jul; 9(7):2083-8. PubMed ID: 8208555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial allelotype of carcinoma in situ of the human bladder.
    Rosin MP; Cairns P; Epstein JI; Schoenberg MP; Sidransky D
    Cancer Res; 1995 Nov; 55(22):5213-6. PubMed ID: 7585577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
    Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
    Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.
    Cairns P; Shaw ME; Knowles MA
    Oncogene; 1993 Apr; 8(4):1083-5. PubMed ID: 8096074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The random development of LOH on chromosome 9q in superficial bladder cancers.
    van Tilborg AA; de Vries A; de Bont M; Groenfeld LE; Zwarthoff EC
    J Pathol; 2002 Nov; 198(3):352-8. PubMed ID: 12375268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel suppressor loci on chromosome 14q in primary bladder cancer.
    Chang WY; Cairns P; Schoenberg MP; Polascik TJ; Sidransky D
    Cancer Res; 1995 Aug; 55(15):3246-9. PubMed ID: 7614456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelotype of human bladder cancer.
    Knowles MA; Elder PA; Williamson M; Cairns JP; Shaw ME; Law MG
    Cancer Res; 1994 Jan; 54(2):531-8. PubMed ID: 8275491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.